CultiSpher
Founded in 1987, Percell Biolytica is one of Sweden's oldest biotech companies.
Our mission
We are committed to the development, production, and commercialization of CultiSpher macroporous microcarriers.
Collaborations and agreements
Strategic collaborations and agreements are key elements of our growth strategy.
Titan Pharmaceutical Inc.
Production of a proprietary microcarrier for Spheramine™. Spheramine™, is a cell based product for the treatment of Parkinson's disease, which utilize non-embryonic, human retinal pigment epithelial (RPE) cells. RPE cells produce dopamine, a neurotransmitter that is lacking in certain brain regions in Parkinson's disease. The product consist of human RPE cells adhered to this proprietary microcarrier which allow for the long term survival and function of cells that are implanted into the mammalian central nervous system. Murine and primate animal studies have demonstrated the ability of a single treatment to significantly reverse Parkinson's like symptoms up to one year.